New risk model could help predict superbug infections in ICUs

NCT ID NCT07603128

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a risk prediction model for MDRGNB, a type of drug-resistant infection, in 1,000 ICU patients across multiple hospitals. Researchers will check how well the model predicts who gets infected, using data collected within 48 hours of ICU admission. The goal is to improve early detection and guide antibiotic use, but this is an observational study, not a treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a reliable tool for predicting MDRGNB infections in ICU patients, helping doctors start the right antibiotics sooner.
What could go wrong
This is an observational study, not a treatment trial. The model may not perform as well in real-world settings, and results may not apply to all hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ankang People's Hospital

    NOT_YET_RECRUITING

    Ankang, China

  • First Affiliated Hospital of Gannan Medical University

    NOT_YET_RECRUITING

    Ganzhou, China

  • Guangxi Provincial Tumor Hospital

    RECRUITING

    Nanning, China

  • Huaian First People's Hospital

    NOT_YET_RECRUITING

    Huaian, China

  • Nanjing Drum Tower Hospital

    RECRUITING

    Nanjing, Jiangsu, 210008, China

  • Shaanxi Provincial People's Hospital

    NOT_YET_RECRUITING

    Xi'an, China

  • Shanghai Ruijin Hospital

    RECRUITING

    Shanghai, China

  • Sinopharm Tongmei General Hospital

    NOT_YET_RECRUITING

    Datong, China

  • Zhanjiang Central People's Hospital

    NOT_YET_RECRUITING

    Zhanjiang, China

  • Zhejiang Hospital

    RECRUITING

    Hangzhou, China

  • Zhejiang Provincial People's Hospital

    NOT_YET_RECRUITING

    Hangzhou, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.